Joseph D. Keegan's most recent trade in Bio-Techne Corp was a trade of 3,511 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on Oct. 24, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Techne | Joseph D. Keegan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2024 | 3,511 | 3,511 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Joseph D. Keegan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2024 | 1,462 | 13,771 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Joseph D. Keegan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2022 | 865 | 865 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Joseph D. Keegan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2022 | 338 | 2,671 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Joseph D. Keegan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 633 | 633 | - | - | Stock Option (right to buy) | |
| Bio-Techne | Joseph D. Keegan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 194 | 2,333 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Joseph D. Keegan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2020 | 1,507 | 1,507 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne | Joseph D. Keegan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2020 | 391 | 2,139 (0%) | 0% | 0 | Common Stock |